Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis

Author:

Nagaraja Vivek1ORCID,Matucci‐Cerinic Marco2,Furst Daniel E.3,Kuwana Masataka4ORCID,Allanore Yannick5,Denton Christopher P.6,Raghu Ganesh7,Mclaughlin Vallerie1,Rao Panduranga S.1,Seibold James R.8,Pauling John D.9ORCID,Whitfield Michael L.10,Khanna Dinesh1ORCID

Affiliation:

1. University of Michigan Ann Arbor

2. University of Florence Florence Italy

3. University of California in Los Angeles, University of Washington, Seattle, and University of Florence Florence Italy

4. Nippon Medical School Tokyo Japan

5. Paris Descartes University, INSERM U1016, Université Sorbonne Paris Cité, and Cochin Hospital Paris France

6. University College London and Royal Free Hospital London UK

7. University of Washington Seattle

8. Scleroderma Research Consultants, LLC Aiken South Carolina

9. Royal National Hospital for Rheumatic DiseasesRoyal United Hospitals Bath UK

10. Geisel School of Medicine at Dartmouth Hanover New Hampshire

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3